AI Business is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Health & Pharma

Lung cancer detection developer Lunglife earns $23.4m in first day on London Stock Exchange

by Ben Wodecki
Article ImageLungLB, the company’s AI-augmented blood-based test, is expected to launch in 2023

California-based LungLife AI, which develops AI-powered lung cancer detection tools, raised £17 million ($23.4m) on its first day of floating on the London Stock Exchange’s Alternative Investment Market (AIM) on Thursday.

Its first day on the public market saw its value rise to £45 million ($62m), with 25,480,790 common shares valued at around 210p ($2.89), up from their issue price of 176p ($2.42).

The company went public to try and raise funds for commercialization of its products and to support the in-licensing of additional technologies.

"We are delighted with the strong support shown by new institutional investors for our fundraiser and we are very proud to complete our admission to AIM, which is a key milestone in the advancement of our AI-enabled LungLB test for early lung cancer detection,” Paul Pagano, LungLife’s CEO said.

From Thousand Oaks to London via Delaware

Founded in 2008, Lunglife is registered in Delaware but operates out of Thousand Oaks, California.

The company is developing tests that span all stages of lung cancer, from aid in diagnosis for patients with early-stage disease to treatment stratification and monitoring in late-stage lung cancer.

Investec Bank acted as nominated adviser and sole broker for the float.

Lunglife said it will now be looking to complete its validation studies and undertake a subsequent utility study of its AI-augmented blood-based LungLB test for indeterminate lung nodules.

LungLB is expected to launch in 2023, the company said. It's designed to provide medical staff with more information on a patient's case and enable better decision-making following a CT scan.

EBooks

More EBooks

Latest video

More videos

Upcoming Webinars

Archived Webinars

More Webinars
AI Knowledge Hub

AI for Everything Series

David Hardoon explaining recent developments in Data Science and AI

Author of Getting Started with Business Analytics: Insightful Decision-Making and the forthcoming book, Creating a Data Culture: Failing to Succeed

AI Knowledge Hub

Research Reports

More Research Reports

Infographics

Smart Building AI

Infographics archive

Newsletter Sign Up


Sign Up